icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 22-26 2022
Back grey_arrow_rt.gif
 
 
 
Peginterferon Lambda (IFN-λ) combined with Lonafarnib
diminished triphasic HDV kinetic pattern seen under IFN-λ
monotherapy: The LIFT-1 Study

 
 
  Sarah Duehren
Research Specialist
 
The Program of Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago
 
Sarah Duehren1, Christopher Koh2, Julian Hercun2, Farial Rahman2, Pallavi Surana2, Anusha Vittal2, Walter Lai2, Ohad Etzion3,
Scott Cotler1, Jeffrey Glenn4, Harel Dahari1, Theo Heller2. 1Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, United States; 2Liver Diseases Branch, NIDDK, NIH, Bethesda, United States; 3Soroka University Medical Center, Beer-Sheba, Israel; 4Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States

0627221

0627222

0627223

0627224

0627225

0627226

0627227

0627228

0627229

06272210

06272211

06272212